These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 35123292)

  • 1. Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.
    Diržiuvienė B; Mickevičienė D
    Mult Scler Relat Disord; 2022 Mar; 59():103558. PubMed ID: 35123292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
    Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
    Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate.
    Doesburg D; Vennegoor A; Uitdehaag BMJ; van Oosten BW
    Mult Scler Relat Disord; 2019 Jun; 31():32-37. PubMed ID: 30901702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring humanistic burden of fatigue in adults with multiple sclerosis: an analysis of US National Health and Wellness Survey data.
    Le HH; Ken-Opurum J; LaPrade A; Maculaitis MC; Sheehan JJ
    BMC Neurol; 2024 Feb; 24(1):51. PubMed ID: 38297247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis.
    Healy BC; Zurawski J; Chitnis T; Weiner HL; Glanz BI
    Qual Life Res; 2022 Jun; 31(6):1799-1805. PubMed ID: 34783972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue in teriflunomide-treated patients with relapsing remitting multiple sclerosis in the real-world Teri-FAST study.
    de Sèze J; Devy R; Planque E; Delabrousse-Mayoux JP; Vandhuick O; Kabir M; Gherib A
    Mult Scler Relat Disord; 2021 Jan; 47():102659. PubMed ID: 33291032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Kowalec K; McKay KA; Patten SB; Fisk JD; Evans C; Tremlett H; Marrie RA;
    Neurology; 2017 Dec; 89(24):2455-2461. PubMed ID: 29117961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
    Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
    Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher-quality diet and non-consumption of meat are associated with less self-determined disability progression in people with multiple sclerosis: A longitudinal cohort study.
    Simpson-Yap S; Nag N; Probst Y; Jelinek G; Neate S
    Eur J Neurol; 2022 Jan; 29(1):225-236. PubMed ID: 34390078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies.
    Mäurer M; Comi G; Freedman MS; Kappos L; Olsson TP; Wolinsky JS; Miller AE; Dive-Pouletty C; Bozzi S; O'Connor PW
    Mult Scler Relat Disord; 2016 May; 7():33-40. PubMed ID: 27237754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients.
    Abbatemarco JR; Ontaneda D; Nakamura K; Husak S; Wang Z; Alshehri E; Bermel RA; Conway DS
    Mult Scler Relat Disord; 2020 Nov; 46():102593. PubMed ID: 33296988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical activity as a correlate of symptoms, quality of life, comorbidity, and disability status in Hispanics with multiple sclerosis.
    Silveira SL; Motl RW; Marquez DX; Lancia S; Salter A
    Disabil Health J; 2023 Apr; 16(2):101398. PubMed ID: 36402726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results.
    Wilken J; Traboulsee A; Nelson F; Ionete C; Kolind S; Fratto T; Kane R; Gandhi R; Rawlings AM; Roesch N; Ozog MA; DeLuca J;
    Mult Scler Relat Disord; 2023 May; 73():104677. PubMed ID: 37028124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.
    Gustavsen S; Olsson A; Søndergaard HB; Andresen SR; Sørensen PS; Sellebjerg F; Oturai A
    BMC Neurol; 2021 Aug; 21(1):317. PubMed ID: 34399707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
    Marck CH; Neate SL; Taylor KL; Weiland TJ; Jelinek GA
    PLoS One; 2016; 11(2):e0148573. PubMed ID: 26849357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.